Piao, X.-M.; Kim, S.-K.; Byun, Y.J.; Zheng, C.-M.; Kang, H.W.; Kim, W.T.; Kim, Y.-J.; Lee, S.-C.; Kim, W.-J.; Moon, S.-K.;
et al. Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups. Int. J. Mol. Sci. 2022, 23, 14481.
https://doi.org/10.3390/ijms232214481
AMA Style
Piao X-M, Kim S-K, Byun YJ, Zheng C-M, Kang HW, Kim WT, Kim Y-J, Lee S-C, Kim W-J, Moon S-K,
et al. Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups. International Journal of Molecular Sciences. 2022; 23(22):14481.
https://doi.org/10.3390/ijms232214481
Chicago/Turabian Style
Piao, Xuan-Mei, Seon-Kyu Kim, Young Joon Byun, Chuang-Ming Zheng, Ho Won Kang, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Wun-Jae Kim, Sung-Kwon Moon,
and et al. 2022. "Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups" International Journal of Molecular Sciences 23, no. 22: 14481.
https://doi.org/10.3390/ijms232214481
APA Style
Piao, X.-M., Kim, S.-K., Byun, Y. J., Zheng, C.-M., Kang, H. W., Kim, W. T., Kim, Y.-J., Lee, S.-C., Kim, W.-J., Moon, S.-K., Choi, Y. H., & Yun, S. J.
(2022). Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups. International Journal of Molecular Sciences, 23(22), 14481.
https://doi.org/10.3390/ijms232214481
